Searching for markers of Creutzfeldt-Jakob disease in cerebrospinal fluid by two-dimensional mapping

被引:28
作者
Piubelli, Chiara [2 ]
Fiorini, Michele [2 ]
Zanusso, Gianluigi [2 ]
Milli, Alberto [3 ]
Fasoli, Elisa [2 ]
Monaco, Salvatore [2 ]
Righetti, Pier Giorgio [1 ]
机构
[1] Milans Polytech, Dept Chem Mat & Engn Chem, Milan, Italy
[2] Univ Verona, Dept Neurol & Visual Sci, Neurol Sect, I-37100 Verona, Italy
[3] Univ Verona, Dept Agr & Ind Biotechnol, I-37100 Verona, Italy
关键词
Cerebrospinal fluid; Creutzfeldt-Jakob disease; Cystatin C; 14-3-3; Proteins; Proteome analysis;
D O I
10.1002/pmic.200500294
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Differential proteomic analysis has been performed on the cerebrospinal fluid (CSF) of six healthy and six patients suffering form sporadic Creutzfeldt-Jakob disease (sCJD), age- and sex-matched, after immuno-subtraction of albumin and immunoglobulins. These maps have revealed 28 polypeptide chains differentially modulated in the sCJD samples, of which 10 appeared to be up-regulated, the remaining 18 being down-regulated. Among those, 13 could be identified upon digestion and MALDI-TOF, MS analysis. In addition, the strong modulation of cystatin C was also confirmed by immunoblot analysis and the highly altered level of the 14-3-3 proteins that escaped detection by 2-D mapping, could be assessed by Western blots and immuno-detection of monomeric and homo-and hetero-dimeric 14-3-3 isotypes. In search for a panel of potential markers for sCJD, we highlight cystatin C, 14-3-3 proteins, transferrin, ubiquitin, Apoliprotein J and perhaps some of the still unidentified, but strongly modulated polypeptide chains detected in the differential map.
引用
收藏
页码:S256 / S261
页数:6
相关论文
共 36 条
[1]   Conservation and amyloid formation: A study of the gelsolin-like family [J].
Benyamini, H ;
Gunasekaran, K ;
Wolfson, H ;
Nussinov, R .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2003, 51 (02) :266-282
[2]   14-3-3 proteins in the nervous system [J].
Berg, D ;
Holzmann, C ;
Riess, O .
NATURE REVIEWS NEUROSCIENCE, 2003, 4 (09) :752-762
[3]   Molecular pathways to neurodegeneration [J].
Bossy-Wetzel, E ;
Schwarzenbacher, R ;
Lipton, SA .
NATURE MEDICINE, 2004, 10 (07) :S2-S9
[4]   PURIFICATION, PROPERTIES, AND IMMUNOHISTOCHEMICAL LOCALIZATION OF HUMAN-BRAIN 14-3-3 PROTEIN [J].
BOSTON, PF ;
JACKSON, P ;
KYNOCH, PAM ;
THOMPSON, RJ .
JOURNAL OF NEUROCHEMISTRY, 1982, 38 (05) :1466-1474
[5]  
Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO
[6]  
2-L
[7]   A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease [J].
Carrette, O ;
Demalte, I ;
Scherl, A ;
Yalkinoglu, O ;
Corthals, G ;
Burkhard, P ;
Hochstrasser, DF ;
Sanchez, JC .
PROTEOMICS, 2003, 3 (08) :1486-1494
[8]   A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431 [J].
Castagna, A ;
Antonioli, P ;
Astner, H ;
Hamdan, M ;
Righetti, SC ;
Perego, P ;
Zunino, F ;
Righetti, PG .
PROTEOMICS, 2004, 4 (10) :3246-3267
[9]   Binding of gelsolin, a secretory protein, to amyloid β-protein [J].
Chauhan, VPS ;
Ray, I ;
Chauhan, A ;
Wisniewski, HM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 258 (02) :241-246
[10]   Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients [J].
Davidsson, P ;
Westman-Brinkmalm, A ;
Nilsson, CL ;
Lindbjer, M ;
Paulson, L ;
Andreasen, N ;
Sjögren, M ;
Blennow, K .
NEUROREPORT, 2002, 13 (05) :611-615